Latest news
DMAC: Positive clinical progress and strong cash runway, despite higher net loss from expanded trials - TradingViewTradingView · Tue, 11 Aug 2026 07:24:22 GMTDMAC Q2'26 Earnings: EPS estimate is (0.20) USD - TradingViewTradingView · Fri, 07 Aug 2026 11:00:20 GMTDMAC Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:15 GMT